US29604W2070 - ADR
PHAXIAM Therapeutics SA
NASDAQ:PHXM (3/8/2024, 8:27:22 PM)
After market: 3.1 0 (0%)3.1
-0.02 (-0.64%)
Phaxiam Therapeutics SA is a FR-based company operating in Biotechnology industry. The company is headquartered in Lyon, Auvergne-Rhone-Alpes and currently employs 49 full-time employees. The company went IPO on 2013-05-07. PHAXIAM Therapeutics SA, formerly known as ERYTECH PHARMA SA, is a France-based biopharmaceutical company developing medicinal products mainly in oncology, hematology and immunology fields of business. The firm relies on the use of phages, natural bacteria-killing viruses. PHAXIAM Therapeutics SA is developing a portfolio of phages targeting three of the most resistant and dangerous bacteria, which alone account for more than two-thirds of resistant nosocomial infections: Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. The company offers ESY-ASP (GRASPA), a medicinal product consisting of L-Asparaginase entrapped into human homologous red blood cells. The product is used for treatment of Acute Lymphoblastic Leukemia (ALL), a childhood cancer.
PHAXIAM Therapeutics SA
60 avenue Rockefeller
Lyon AUVERGNE-RHONE-ALPES
P: 33478744438
Employees: 49
Website: https://erytech.com/
Listing market: Euronext Paris (Market segment C - ISIN Code: FR001400K4B1- Symbol: PHXM) Website : www.phaxiam.com DateTotal of shares composing the...
Place de cotation : Euronext Paris (Compartiment C - Code ISIN : FR001400K4B1 – Symbole : PHXM) Site web : www.phaxiam.com DateNombre total d’actions...
A Phase 2 study sponsored by Assistance Publique – Hôpitaux de Paris (AP-HP) as part of the hospital-based clinical research program (PHRC)Evaluation of...
Étude de phase 2 sponsorisée par l'Assistance Publique – Hôpitaux de Paris (AP-HP) dans le cadre du Programme Hospitalier de Recherche Clinique...
Continuous commitment to create a global leader in phage therapies to treat severe and resistant bacterial infections Ambitious development strategy on...
Rapport Financier Semestriel 30 Juin 2024 PHAXIAM Pièce jointe PHXM_RFS_2024 ...
Here you can normally see the latest stock twits on PHXM, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: